OminiWell Pty Ltd

OminiWell has developed an innovative BioTwin chip (3D microtissue-on-a-chip) technology for culturing human tissues. This chip takes the key elements of a person’s biological system to recreate a ’biological twin’ within a 3D cell structure for the purpose of optimising and testing personalised precision medicine.

This tissue culture platform is suitable for testing various cancer types coupled with personalised treatment recommendations for selecting personalised medicine.

This microtissue-on-a-chip will be initially developed as a cell culture consumable for the preclinical drug discovery validation, and ultimately used as an in vitro diagnostic device for selecting personalised treatments.